FETROJA Accelagen Pty Ltd
Product name
FETROJA
Sponsor
Accepted date
Dec-2024
Active ingredients
cefiderocol sulfate tosilate
Proposed indication
Fetroja is an anti-bacterial drug for the treatment of infections caused by aerobic Gram-negative organisms in adults with limited treatment options.
Application type
A (new medicine)
Publication date
Dec-2024